British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine
British drugmaker GlaxoSmithKline Plc is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) to contribute towards the effort of developing a vaccine for the coronavirus outbreak, GSK and CEPI said on Monday.
No comments:
Post a Comment